Cargando…
High Frequency of ASXL1 and IDH Mutations in Young Acute Myeloid Leukemia Egyptian Patients
BACKGROUND: Prognostication of AML patients depends on association of genetic and epigenetic abnormalities. We aimed to evaluate the frequency and prognostic significance of Additional Sex comb’s Like1 (ASXL1), Isocitrate Dehydrogenase (IDH) and Casitas B- lineage Lymphoma (CBL) mutations in AML ass...
Autores principales: | El Nahass, Yasser H, Nader, Heba A, Sabet, Salwa, Nooh, Hend A, Bassiony, Heba, Kamel, Mahmoud, Samra, Mohamed A, Mahmoud, Hossam K, El Metnawy, Wafaa H, El Refaey, Fatma A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360955/ https://www.ncbi.nlm.nih.gov/pubmed/35345371 http://dx.doi.org/10.31557/APJCP.2022.23.3.977 |
Ejemplares similares
-
IDH Mutations in AML Patients; A higher Association with Intermediate Risk Cytogenetics
por: ElNahass, Yasser H, et al.
Publicado: (2020) -
Predictive Value of Pretreatment BCR-ABL(IS) Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML)
por: El-Metnawy, Wafaa H., et al.
Publicado: (2013) -
Magnetite Nanoparticles Inhibit Tumor Growth and Upregulate the Expression of P53/P16 in Ehrlich Solid Carcinoma Bearing Mice
por: Bassiony, Heba, et al.
Publicado: (2014) -
Tissue Distribution, Histopathological and Genotoxic Effects of Magnetite Nanoparticles on Ehrlich Solid Carcinoma
por: Bassiony, Heba, et al.
Publicado: (2022) -
Kinetics of BCR-ABL Transcripts in Imatinib Mesylate treated Chronic Phase CML (CPCML), A Predictor of Response and Progression Free Survival
por: Mahmoud, Hossam K, et al.
Publicado: (2009)